Conferences
ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
WIN 2012
28 - 29 Jun 2012
France
The WINTHER study
Prof Razelle Kurzrock - MD Anderson Cancer Center, Houston, USA
16 Jul 2012
Use of electronic data to raise the standard of cancer care
Brett Davis – Oracle Corporation, USA
16 Jul 2012
Drugging the cancer genome: opportunities and challenges
Prof Paul Workman - Institute of Cancer Research, UK
16 Jul 2012
A new direction for development of targeted cancer therapies
Dr Edison Liu – Jackson Laboratory, USA
16 Jul 2012
Online collaborations to aid treatment development
Dr Patrick Johnson - Dassault Systems, France
13 Jul 2012
Addressing Asia’s high cancer incidence
Dr Bin Teh - SingHealth Group, Singapore
13 Jul 2012
Vandetanib increases progression free survival in medullary thyroid carcinoma
Dr Nick Botwood - AstraZeneca, UK
13 Jul 2012
WINTHER: The WIN therapeutics clinical trial
Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Sp...
13 Jul 2012
Use of genetic variance to identify potential therapeutic targets
Dr John Quackenbush - Dana-Farber Cancer Institute, Boston, USA
11 Jul 2012
Introduction of PET tracers to the WINTHER trial
Robert Dann - Global Strategy Leader, Oncology/Pathology, GE Healthcare
11 Jul 2012
Application of next generation sequencing
Dr Gary Palmer – Foundation Medicine, Cambridge, USA
6 Jul 2012
Next generation sequencing and WIN therapeutics
Dr Michael Pellini – Foundation Medicine, Cambridge, USA
6 Jul 2012
Identifying targets with systems medicine
Dr Leroy Hood – Institute for Systems Biology, USA
6 Jul 2012
Importance of early detection and the ‘Beyond the Shock’ programme
Dr Douglas Feil – National Breast Cancer Foundation, USA
6 Jul 2012
Shortening the timeline for clinical drug developments
Dr James Doroshow – National Cancer Institute, Bethesda, USA
6 Jul 2012
Building international collaborations and the WINTHER trial
Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA
6 Jul 2012
